Author: T. A. Sos 1 , 2
View More View Less
  • 1 New York Presbyterian Hospital, Weill Cornell, USA
  • 2 525 East 68th Steet, Payson 521, New York, NY, 10065, USA
Restricted access

Abstract

ASTRAL and STAR, two recent prospective randomized trials to compare renal artery stenting with optimal medical management versus optimal medical management alone for patients with renal insufficiency and renal artery stenosis, have concluded that there was no additional benefit to stenting. Patient selection and methodological issues in these studies cast doubt on the validity of their results and conclusions for patients with renal insufficiency and physiologically (hemodynamically) significant renal artery stenosis, i.e. true ischemic nephropathy.

  • 1. K. Wheatley N. Ives R. Gray P.A. Kalra J.G. Moss C. Baigent S. Carr N. Chalmers D. Eadington G. Hamilton G. Lipkin A. Nicholson J. Scoble 2009 Revascularization versus medical therapy for renal-artery stenosis N Engl J Med 361 1953 1962.

    • Search Google Scholar
    • Export Citation
  • 2. L. Bax A.-J. Woittiez H.J. Kouwenberg 2009 Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function. A randomized trial Ann InternMed 150 840 848.

    • Search Google Scholar
    • Export Citation
  • 3. T.A. Sos D.W. Trost 2008 Renovascular hypertension Kandarpa Peripheral Vascular Interventions Lippincott Williams & Wilkins Philadelphia, PA 287 314.

    • Search Google Scholar
    • Export Citation
  • 4. A.T. Hirsch Z.J. Haskal N.R. Hertzer C.W. Bakal M.A. Creager J.L. Halperin L.F. Hiratzka W.R. Murphy J.W. Olin J.B. Puschett K.A. Rosenfield D. Sacks J.C. Stanley L.M. Taylor Jr C.J. White J. White R.A. White E.M. Antman S.C. Smith Jr C.D. Adams J.L. Anderson D.P. Faxon V. Fuster R.J. Gibbons J.L. Halperin L.F. Hiratzka S.A. Hunt A.K. Jacobs R. Nishimura J.P. Ornato R.L. Page B. Riegel 2006 ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery. Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation J Am Coll Cardiol 47 1239 1312.

    • Search Google Scholar
    • Export Citation
  • 5. M. Imanishi S. Akabane M. Takamiya M. Kawamura Y. Matsushima M. Kuramochi T. Omae 1992 Critical degree of renal arterial stenosis that causes hypertension in dogs Angiology 43 833 842.

    • Search Google Scholar
    • Export Citation
  • 6. G. Simon 2000 What is critical renal artery stenosis? Implications for treatment Am J Hypertens 13 1189 1193.

  • 7. B.C. van Jaarsveld H. Pieterman L.C. van Dijk A.J. van Seijen P. Krijnen F.H. Derkx A.J. Man in't Veld M.A. Schalekamp 1999 Inter-observer variability in the angiographic assessment of renal artery stenosis. DRASTIC study group. Dutch Renal Artery Stenosis Intervention Cooperative Journal of Hypertension 17 1731 1736.

    • Search Google Scholar
    • Export Citation
  • 8. B. De Bruyne G. Manoharan N.H. Pijls K. Verhamme J. Madaric J. Bartunek M. Vanderheyden G.R. Heyndrickx 2006 Assessment of renal artery stenosis severity by pressure gradient measurements J Am Coll Cardiol 48 1851 1855.

    • Search Google Scholar
    • Export Citation
  • 9. M.S. Edwards M.A. Corriere 2009 Contemporary management of atherosclerotic renovascular disease J Vasc Surg 50 1197 1210.

  • 10. C.M. Cheung A. Patel N. Shaheen S. Cain H. Eddington J. Hegarty 2007 The effects of statins on the progression of atherosclerotic renovascular disease Nephron Clin Pract 107 c35 42.

    • Search Google Scholar
    • Export Citation
  • 11. P. Ruggenenti A. Perna R. Benini G. Remuzzi 1998 Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN) J Am Soc Nephrol 9 2096 2101.

    • Search Google Scholar
    • Export Citation